137 related articles for article (PubMed ID: 2934788)
1. Clinical experience with aztreonam in Europe: a summary of studies in Belgium, England, Finland, Ireland, the Netherlands, Norway, Portugal, and Sweden.
Norrby SR
Rev Infect Dis; 1985; 7 Suppl 4():S836-9. PubMed ID: 2934788
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with aztreonam in four Mediterranean countries.
Daikos GK
Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
[TBL] [Abstract][Full Text] [Related]
3. Aztreonam therapy for serious gram-negative bacillary infections.
Cone LA; Woodard DR
Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with aztreonam in the treatment of gram-negative bacteremia.
Scully BE; Henry SA
Rev Infect Dis; 1985; 7 Suppl 4():S789-93. PubMed ID: 3909338
[TBL] [Abstract][Full Text] [Related]
5. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli.
Simons WJ; Lee TJ
Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786
[TBL] [Abstract][Full Text] [Related]
6. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
7. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Scully BE; Neu HC
Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
[TBL] [Abstract][Full Text] [Related]
8. Clinical studies of aztreonam in Japan.
Hara K; Kobayashi H; Nishiura T; Yura J; Saito A
Rev Infect Dis; 1985; 7 Suppl 4():S810-24. PubMed ID: 3909341
[TBL] [Abstract][Full Text] [Related]
9. Aztreonam: the first monobactam.
Neu HC
Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
[TBL] [Abstract][Full Text] [Related]
10. Aztreonam therapy for serious gram-negative infections in children.
Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of aztreonam in the treatment of serious gram-negative infections in a university hospital in Saudi Arabia.
Fayed DF; Dahmash NS; Saddique AA; Shibl AM
J Chemother; 1992 Jun; 4(3):167-70. PubMed ID: 1517810
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
Clergeot A; Steru D; Rosset MA; Carbon C
Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
[TBL] [Abstract][Full Text] [Related]
13. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
Henry SA; Bendush CB
Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
[TBL] [Abstract][Full Text] [Related]
14. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
Swabb EA; Jenkins SA; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
McKellar PP
Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
[TBL] [Abstract][Full Text] [Related]
16. Overall clinical experience with aztreonam in the treatment of intraabdominal infections.
Henry SA
Rev Infect Dis; 1985; 7 Suppl 4():S729-33. PubMed ID: 3909331
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with aztreonam in Germany and Austria.
Stille W; Gillissen J
Rev Infect Dis; 1985; 7 Suppl 4():S825-30. PubMed ID: 3909342
[TBL] [Abstract][Full Text] [Related]
18. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
Rabinad E; Bosch-Perez A
Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
[TBL] [Abstract][Full Text] [Related]
19. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Brogden RN; Heel RC
Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
[TBL] [Abstract][Full Text] [Related]
20. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
Constantopoulos A; Thomaidou L; Loupa H; Papoulias G
Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
